Health and Human Services leaders are “optimistic” about the future of artificial intelligence in medicine. However, they won’t trust without verifying.
Health and Human Services leaders are “optimistic” about the future of artificial intelligence (AI) in medicine. However, they won’t trust without verifying, National Coordinator for Health Information Technology Micky Tripathi, PhD, MPP, said. Tripathi testified on December 13, 2023, at the “Leveraging Agency Expertise to Foster American AI Leadership and Innovation” hearing as part of the US House of Representatives’ House Committee on Energy & Commerce.1
“AI-based technologies have the potential to accelerate innovation, increase competition, help to ameliorate health inequities, reduce clinician burnout, and improve care and the care experience for patients,” Tripathi said in his statement. However, Tripathi also said that “we know that there are potential downsides,” so HHS leaders believe their posture on AI must be to trust but verify.
HHS is already overseeing research and drafting rules regarding AI in health care. The FDA has approved nearly 700 AI-enabled devices for use in the market. The National Institutes of Health, the Office for Civil Rights, and the CMS all have programs underway to study and regulate AI, Tripathi said. He also noted that the HHS published its final Health Data, Technology, and Interoperability: Certification Program Updates, Algorithm Transparency, and Information Sharing rule. The rule governs patient access, standards, algorithm transparency, and interoperability-focused reporting metrics for certified health information technology. The Office of the National Coordinator for Health Information Technology certifies the electronic health records used by of hospitals and of physician offices.
“Electronic health records are a key enabler of AI in health care,” Tripathi said. “They are increasingly the source of data that feeds machine learning algorithms and where AI works behind the scenes and with user interfaces and workflows to influence data to this day-to-day decision-making that directly affects patient lives.” But health care providers are concerned about AI serving as a “black box on their system,” and that is hindering adoption of the new technologies; however, HHS leaders believe the new rule could spur adoption, Tripathi said.
“With transparency and risk management to instill public trust and confi dence, AI opens up vast opportunities to improve our country’s health care, public health, and social services capabilities to better serve the American people,” Tripathi said. “These objectives will enable to fully mobilize its components to seamlessly integrate with and meaningfully contribute to a whole-of-government-and-industry approach to improving quality, efficiency, trustworthiness, access, and outcomes in health and human services through the safe, ethical, and responsible use of AI [FIGURE],” he said.
Overcoming Barriers in Cancer Clinical Trials: A Path Forward for Better Patient Care
April 29th 2024Clinical trials play a pivotal role in developing effective therapies, yet their integration is challenged by issues such as insufficient reimbursement structures, misaligned incentives, physician burnout, and a complex regulatory environment.
Read More
Gholam Analyzes Treatment Outcomes for Advanced HCC in Child-Pugh B Population
April 28th 2024During a live Community Case Forum event in partnership with the Tennessee Oncology Practice Society, Pierre Gholam, MD, examined the current state of treatment for patients with hepatocellular carcinoma, looking in particular at what data is available for those with Child-Pugh B and C status who have poorer outcomes and have limited data from prospective clinical trials.
Read More